Cepheid’s updated Winter Care Bundle of Xpert® molecular diagnostic tests is an essential tool kit in the battle against virulent infections. Consisting of the Xpert Norovirus, Xpert C. difficile BT, Xpert Carba-R, Xpert vanA/vanB and Xpert Flu/RSV XC rapid tests for the GeneXpert® System, it offers on-demand RT¬PCR testing to help avoid preventable ward closures and avert a winter care crisis.
Molecular diagnostic testing with Cepheid’s GeneXpert System provides rapid, accurate diagnoses, minimising the impact on hospital resources by enabling immediate implementation of infection control procedures and initiation of appropriate treatment. Offering results in just 45 to 90 minutes, the Winter Care Bundle can help to prevent the spread of disease and improve patient management, as well as antibiotic and antiviral stewardships, reducing the potential burden of viral outbreaks. The new Xpert C. difficile BT not only returns results for toxins A and B, but also reports binary toxin status independently. This helps to detect a wider range of hypervirulent strains and track novel strains that are negative for toxins A and B, but positive for CDT. Xpert C. difficile BT is complemented by Xpert Norovirus – which can efficiently detect and differentiate between norovirus GI and GII – and Xpert vanA/vanB, offering effective surveillance for both the vanA and vanB vancomycin-resistance operons. Xpert Carba-R is designed to identify the most prevalent carbapenemase gene families (KPC, NDM, VIM, IMP-1, OXA-48, OXA-181 and OXA-232), and Xpert Flu/RSV XC – a multiplexed test for fast and accurate differentiation of Flu A, Flu B and respiratory syncytial virus – completes the Winter Care Bundle.
